Dopamine levels are higher in patients with PCOS [17], and dopamine infusions have been shown to induce a significant reduction in LH levels in humans, and bromocriptine, a dopamine agonist, has demonstrated efficacy in reducing LH:FSH ratios and restoring ovarian function in women with PCOS [18, 19]. Here, PLOD1 is linked to polycystic ovary syndrome.